Jynarque
Ended Awarded
- Contract number
- 36C26124N0273
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $24,449
Award facts
- Contract value 100% obligated
- $24,449.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. received a $24,449.20 delivery order for Jynarque (tolvaptan) from the Department of Veterans Affairs Veterans Integrated Service Network 21, with an award date of November 22, 2023 and completion date of January 22, 2024. This firm-fixed price contract was issued without a set-aside designation and specifies performance at the contractor's location in Potomac, Maryland. Jynarque is a specialty pharmaceutical indicated for treating autosomal dominant polycystic kidney disease and hyponatremia in veteran populations.
This delivery order is issued under Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement vehicle—an $83.3 million indefinite delivery/indefinite quantity contract for Jynarque established through the National Acquisition Center under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The BPA, which extends through March 26, 2026, enables VA integrated service networks nationwide to procure this critical specialty pharmaceutical efficiently. As an established large pharmaceutical manufacturer with a $396 million Federal Supply Schedule contract, Otsuka America Pharmaceutical Inc. has demonstrated capability to support the VA's mission of providing specialized pharmaceutical treatments to veterans across multiple service networks.
Quick answers
Who was awarded contract 36C26124N0273?
36C26124N0273 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on November 22, 2023.
How much is contract 36C26124N0273 worth?
The government has obligated $24,449 on 36C26124N0273.
Is contract 36C26124N0273 an order under another contract?
Yes. 36C26124N0273 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0273 competed?
The extent of competition for 36C26124N0273 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award